Filana Therapeutics, Inc. (FLNA) stock
FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.64+0.08 (+14.52%)
Close on Nov 20, 2026Market cap $30.98MP/E –Yield –
Filana Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Filana Therapeutics's price to sales ratio was 6.3× on Apr 30, 2014, against 17.1× a year earlier. Over the last 2 years it ranged from 6.1× to 26.2×, with a median of 14.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2014 | Apr 30, 2014 | 6.3× | −19.9 |
| 2013 | Dec 31, 2013 | 26.2× | +10.4 |
| 2012 | Apr 30, 2012 | 15.8× | +3.5 |
| 2011 | Jul 29, 2011 | 12.3× | – |
See a number that looks wrong?